Clinical Performance Study of a New Fully Automated Red Blood Cell Permeability Fragility Analyzer

J Healthc Eng. 2022 Mar 29:2022:5642907. doi: 10.1155/2022/5642907. eCollection 2022.

Abstract

In order to verify the applicability of the erythrocyte fragility test (EFT) carried out by the new fully automatic erythrocyte permeability fragility analyzer RA-800 for thalassemia screening, a total of 100 cases of suspected thalassemia patients who underwent pregnancy examinations at Luohu District People's Hospital are included. The results of a new automatic erythrocyte permeability fragility analyzer RA-800 are compared with the results of the detection system composing of the KOFA erythrocyte fragility test kit currently used in clinical laboratories. The diagnosis confirmed by genetic testing is used as the gold standard to evaluate the applicability of RA-800. The sensitivity, specificity, and accuracy of the new automatic erythrocyte permeability fragility analyzer RA-800 screening for thalassemia were 66.67%, 92.86%, and 85.00%. The KOFA direct colorimetries are 76.67%, 81.43%, and 80.00%. The kappa value for the screening of thalassemia was 0.558, which concludes that the consistency was moderate. The ROC curve indicates that both two methods had diagnostic significance for the diagnostic value of thalassemia. The new automatic erythrocyte permeability fragility analyzer RA-800 is suitable for thalassemia screening, and the performance indexes meet the clinical requirements.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Erythrocyte Indices*
  • Erythrocytes
  • Female
  • Humans
  • Osmotic Fragility
  • Permeability
  • Pregnancy
  • Sensitivity and Specificity
  • Thalassemia* / diagnosis